Conference Detail

Family Medicine Conference Details

Bone Health 2014 CME

March 29, 2014
Dallas, Texas 75390, United States
The aim of this symposium is to provide the latest knowledge and discuss controversies related to the pathogenesis and management of primary osteoporosis and drug-induced osteoporosis as well as covering current topics on mineral disorders in special populations such as patients with chronic kidney disease or kidney stones. The format of this symposium will be a series of lectures presented by experts in the field on a variety of topics followed by panel discussions where the audience can directly interact with the speakers.

7.25 AMA PRA Category 1 Credits™ - maximum

Venue: UT Southwestern Medical Center
Conference Full List

Prepare for This Meeting

Read Article Summaries From Top Medical Journals

Related Quizzes From Smartest Doc

Question: Which outcome is significantly greater with daily teriparatide in patients with postmenopausal osteoporosis and RA compared to those with only postmenopausal osteoporosis?

Question: What is the only hormone that is a known regulator of both bone mineralization and bone adiposity?

Question: True or false: Prolonged reduction in bone turnover during 10 years of therapy with alendronate leads to adverse effects on bone material properties in postmenopausal women.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here